Dogwood Therapeutics (DWTX) Amortization of Deferred Charges (2020 - 2026)
Dogwood Therapeutics (DWTX) posted quarterly Amortization of Deferred Charges of $16839.0 for Q1 2026, down 67.85% year-over-year from $52373.0 in Q1 2025, and down 67.85% quarter-over-quarter from $52373.0 in Q1 2025.
Dogwood Therapeutics (DWTX) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Dogwood Therapeutics (DWTX) has reported Amortization of Deferred Charges for 3 consecutive years, with $16839.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 67.85% year-over-year to $16839.0; the TTM figure through Mar 2026 stood at $16839.0 (down 82.41% YoY), while the FY2025 annual figure was $52373.0, down 10.37% from the prior year.
- Amortization of Deferred Charges eased to $16839.0 in Q1 2026 per DWTX's latest filing, from $52373.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $52373.0 in Q1 2025 and bottomed at $16839.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dogwood Therapeutics | 84.98 Mn | 84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,839.00 |
| Mar 31, 2026 | 16,839.00 |
| Mar 31, 2025 | 52,373.00 |
| Mar 31, 2025 | 52,373.00 |
| Dec 31, 2020 | 11,912.00 |
| Dec 31, 2020 | 11,912.00 |
| Sep 30, 2020 | 14,750.00 |
| Sep 30, 2020 | 14,750.00 |
| Jun 30, 2020 | 16,698.00 |
| Jun 30, 2020 | 16,698.00 |
| Mar 31, 2020 | 10,623.00 |
| Mar 31, 2020 | 10,623.00 |